Feasibility of a surveillance programme based on gargle samples and pool testing to prevent SARS-CoV-2 outbreaks in schools.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 09 2021
Historique:
received: 27 05 2021
accepted: 15 09 2021
entrez: 1 10 2021
pubmed: 2 10 2021
medline: 21 10 2021
Statut: epublish

Résumé

School closures have a negative impact on physical and mental well-being, and education, of children and adolescents. A surveillance programme to detect asymptomatic SARS-CoV-2 infection could allow schools to remain open, while protecting the vulnerable. We assessed the feasibility of a programme employing gargle samples and pool testing of individually extracted RNA using rRT-qPCR in a primary and a secondary school in Germany, based on programme logistics and acceptance. Twice a week, five participants per class were selected to provide samples, using an algorithm weighted by a risk-based priority score to increase likelihood of case detection. The positive response rate was 54.8% (550 of 1003 pupils). Logistics evaluation revealed the rate-limiting steps: completing the regular pre-test questionnaire and handing in the samples. Acceptance questionnaire responses indicated strong support for research into developing a surveillance programme and a positive evaluation of gargle tests. Participation was voluntary. As not all pupils participated, individual reminders could lead to participant identification. School-wide implementation of the programme for infection monitoring purposes would enable reminders to be given to all school pupils to address these steps, without compromising participant anonymity. Such a programme would provide a feasible means to monitor asymptomatic respiratory tract infection in schools.

Identifiants

pubmed: 34593887
doi: 10.1038/s41598-021-98849-1
pii: 10.1038/s41598-021-98849-1
pmc: PMC8484445
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19521

Informations de copyright

© 2021. The Author(s).

Références

Pediatr Allergy Immunol. 2021 May;32(4):762-770
pubmed: 33512035
Lancet Reg Health Eur. 2021 Jun;5:100086
pubmed: 34396360
Lancet Child Adolesc Health. 2020 Nov;4(11):817-827
pubmed: 32758453
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
GMS Hyg Infect Control. 2020 Sep 15;15:Doc22
pubmed: 32974120
Sci Transl Med. 2021 Apr 14;13(589):
pubmed: 33619080
JMIR Res Protoc. 2021 May 28;10(5):e28673
pubmed: 33979297
Eur Child Adolesc Psychiatry. 2022 Jun;31(6):879-889
pubmed: 33492480
Clin Infect Dis. 2020 Nov 5;71(8):1980-1981
pubmed: 32271374
Infect Control Hosp Epidemiol. 2021 Nov;42(11):1340-1344
pubmed: 33436122
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Indian J Med Res. 2020 Jul & Aug;152(1 & 2):77-81
pubmed: 32820725
J Paediatr Child Health. 2020 Jul;56(7):1013-1017
pubmed: 32619327
Health Promot Perspect. 2020 Nov 07;10(4):293-294
pubmed: 33312923
Nat Commun. 2021 Mar 5;12(1):1467
pubmed: 33674580
J Clin Microbiol. 2021 Mar 19;59(4):
pubmed: 33514627
Euro Surveill. 2020 Sep;25(38):
pubmed: 32975186
Infect Control Hosp Epidemiol. 2021 Feb;42(2):248-249
pubmed: 32389132
Lancet. 2020 May 2;395(10234):1420-1421
pubmed: 32325027
Paediatr Child Health (Oxford). 2020 Dec;30(12):430-437
pubmed: 32959000
Monatsschr Kinderheilkd. 2021;169(1):52-56
pubmed: 33353989
Am J Clin Pathol. 2020 May 5;153(6):715-718
pubmed: 32304208
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413743
Psychiatry Res. 2021 Jan;295:113560
pubmed: 33187723
Lancet Public Health. 2020 May;5(5):e243-e244
pubmed: 32275858
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Euro Surveill. 2021 Aug;26(34):
pubmed: 34448448
Viruses. 2021 Apr 10;13(4):
pubmed: 33920072
Arch Dis Child. 2021 Feb;106(2):111-113
pubmed: 32747375
J Virol Methods. 2021 Sep;295:114184
pubmed: 34029634
Clin Infect Dis. 2020 Nov 19;71(16):2073-2078
pubmed: 32358960
BMJ Open. 2020 Sep 29;10(9):e042867
pubmed: 32994262
Obesity (Silver Spring). 2020 Jun;28(6):1008-1009
pubmed: 32227671
Front Pediatr. 2021 Mar 16;9:645577
pubmed: 33796490
GMS Hyg Infect Control. 2020 May 28;15:Doc11
pubmed: 32547911
J Clin Virol. 2015 Mar;64:59-63
pubmed: 25728080

Auteurs

Catherine M Sweeney-Reed (CM)

Neurocybernetics and Rehabilitation, Dept. of Neurology, Medical Faculty, Otto von Guericke University Magdeburg, Leipziger Str. 44, Magdeburg, Germany. catherine.sweeney-reed@med.ovgu.de.
Center for Behavioral Brain Sciences, Otto von Guericke University Magdeburg, Magdeburg, Germany. catherine.sweeney-reed@med.ovgu.de.

Doreen Wolff (D)

Institute of Social Medicine and Health System Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Sarah Hörnschemeyer (S)

Institute of Social Medicine and Health System Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Henriette Faßhauer (H)

Institute of Social Medicine and Health System Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Antonia Haase (A)

Institute of Social Medicine and Health System Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Dirk Schomburg (D)

Institute of Biometry und Medical Informatics (IBMI), Otto von Guericke University Magdeburg, Magdeburg, Germany.

Jakob Niggel (J)

University of Regensburg, Regensburg, Germany.
MaganaMed GmbH, Regensburg, Germany.

Michael Kabesch (M)

University Children's Hospital Regensburg (KUNO), Hospital St. Hedwig of the Order of St. John, Regensburg, Germany.
Research and Development Campus Regensburg (WECARE), Hospital St. Hedwig of the Order of St. John and University of Regensburg, Regensburg, Germany.

Christian Apfelbacher (C)

Institute of Social Medicine and Health System Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Research and Development Campus Regensburg (WECARE), Hospital St. Hedwig of the Order of St. John and University of Regensburg, Regensburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH